Insider Transactions Reported by 18 Insiders of Barinthus Biotherapeutics plc.

Symbol
BRNS on Nasdaq
Location
Germantown, MD

There are no Buy or Sell transactions made by insiders since 12 Mar 2025

Barinthus Biotherapeutics plc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Geoffrey Lynn Chief Scientific Officer $1,560,994 17 Dec 2024
Leon Hooftman Chief Medical Officer 03 Feb 2025
KAREN A. DAWES Director 10 Jun 2025
Graham Griffiths Chief Business Officer 03 Feb 2025
Gemma Brown Chief Financial Officer 03 Feb 2025
Joseph Scheeren Director 10 Jun 2025
Nadege Pelletier Chief Scientific Officer 02 Jan 2024
Alex Hammacher Director 10 Jun 2025
Robin Wright Director 10 Jun 2025
William Enright Chief Executive Officer, Director 03 Feb 2025
Anne M. Phillips Director 10 Jun 2025
Pierre A. Morgon Director 10 Jun 2025
M&G Alternatives Investment Management Ltd 10%+ Owner 30 Sep 2022
Thomas George Evans Fmr Chief Scientific Officer 03 Jan 2023
Georgy Egorov Chief Financial Officer 03 Jan 2022
Christopher Ellis Chief Operating Officer 03 Jan 2023
Margaret Marshall Chief Medical Officer 03 Jan 2023
M&G INVESTMENT MANAGEMENT LTD 10%+ Owner 30 Sep 2022

Recent Insider Transactions by Companies or Individuals for Barinthus Biotherapeutics plc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Alex Hammacher BRNS Share Option (Right to Buy) Award 20,174 20,174 10 Jun 2025 Direct
Robin Wright BRNS Share Option (Right to Buy) Award 20,174 20,174 10 Jun 2025 Direct
Pierre A. Morgon BRNS Share Option (Right to Buy) Award 20,174 20,174 10 Jun 2025 Direct
Anne M. Phillips BRNS Share Option (Right to Buy) Award 20,174 20,174 10 Jun 2025 Direct
Joseph Scheeren BRNS Share Option (Right to Buy) Award 20,174 20,174 10 Jun 2025 Direct
KAREN A. DAWES BRNS Share Option (Right to Buy) Award 20,174 20,174 10 Jun 2025 Direct
Gemma Brown BRNS Share Option (Right to Buy) Award 160,000 160,000 03 Feb 2025 Direct
William Enright BRNS Share Option (Right to Buy) Award 600,000 600,000 03 Feb 2025 Direct
Graham Griffiths BRNS Share Option (Right to Buy) Award 200,000 200,000 03 Feb 2025 Direct
Leon Hooftman BRNS Share Option (Right to Buy) Award 140,000 140,000 03 Feb 2025 Direct
Leon Hooftman BRNS Share Option (Right to Buy) Award 195,166 195,166 03 Jun 2024 Direct
KAREN A. DAWES BRNS Share Option (Right to Buy) Award 19,516 19,516 10 May 2024 Direct
Joseph Scheeren BRNS Share Option (Right to Buy) Award 19,516 19,516 10 May 2024 Direct
Anne M. Phillips BRNS Share Option (Right to Buy) Award 19,516 19,516 10 May 2024 Direct
Alex Hammacher BRNS Share Option (Right to Buy) Award 19,516 19,516 10 May 2024 Direct
Pierre A. Morgon BRNS Share Option (Right to Buy) Award 19,516 19,516 10 May 2024 Direct
Robin Wright BRNS Share Option (Right to Buy) Award 19,516 19,516 10 May 2024 Direct
Nadege Pelletier BRNS Share Option (Right to Buy) Award 105,000 105,000 02 Jan 2024 Direct
Graham Griffiths BRNS Share Option (Right to Buy) Award 96,500 96,500 02 Jan 2024 Direct
William Enright BRNS Share Option (Right to Buy) Award 443,981 443,981 02 Jan 2024 Direct
Gemma Brown BRNS Share Option (Right to Buy) Award 193,000 193,000 02 Jan 2024 Direct
Joseph Scheeren BRNS Ordinary Shares Purchase 76.9% $24,400 $2.44 10,000 23,000 26 Jun 2023 Direct
Robin Wright BRNS Ordinary Shares Purchase 39.8% $36,612 $2.66 13,750 48,256 25 May 2023 Direct
Pierre A. Morgon BRNS Share Option (Right to Buy) Award 19,197 19,197 11 May 2023 Direct
Robin Wright BRNS Share Option (Right to Buy) Award 19,197 19,197 11 May 2023 Direct
Joseph Scheeren BRNS Share Option (Right to Buy) Award 19,197 19,197 11 May 2023 Direct
Alex Hammacher BRNS Share Option (Right to Buy) Award 19,197 19,197 11 May 2023 Direct
Anne M. Phillips BRNS Share Option (Right to Buy) Award 19,197 19,197 11 May 2023 Direct
KAREN A. DAWES BRNS Share Option (Right to Buy) Award 19,197 19,197 11 May 2023 Direct
William Enright BRNS Ordinary Shares Sale -2.02% $36,298 $2.42 -15,000 728,454 27 Mar 2023 By Trust
Nadege Pelletier BRNS Share Option (Right to Buy) Award 485,000 485,000 01 Feb 2023 Direct
Margaret Marshall BRNS Share Option (Right to Buy) Award 60,000 60,000 03 Jan 2023 Direct
Thomas George Evans BRNS Share Option (Right to Buy) Award 125,000 125,000 03 Jan 2023 Direct
Graham Griffiths BRNS Share Option (Right to Buy) Award 105,000 105,000 03 Jan 2023 Direct
Christopher Ellis BRNS Share Option (Right to Buy) Award 105,000 105,000 03 Jan 2023 Direct
Gemma Brown BRNS Share Option (Right to Buy) Award 33,100 33,100 03 Jan 2023 Direct
William Enright BRNS Share Option (Right to Buy) Award 440,000 440,000 03 Jan 2023 Direct
M&G Alternatives Investment Management Ltd BRNS American Depositary Shares Other -100% -4,108,752 0 30 Sep 2022 Please see footnote
M&G Investment Management Ltd BRNS American Depositary Shares Other 377.4% 4,108,752 5,197,349 30 Sep 2022 Please see footnote
Gemma Brown BRNS Share Option (Right to Buy) Award 334,000 334,000 26 Sep 2022 Direct
Graham Griffiths BRNS Ordinary Shares Sale -8.76% $73,870 $7.39 -10,000 104,209 25 Aug 2022 Direct
Christopher Ellis BRNS Ordinary Shares Options Exercise 52234.7% 39,176 39,251 25 Aug 2022 Direct
Christopher Ellis BRNS Ordinary Shares Sale -99.8% $257,396 $6.57 -39,176 75 25 Aug 2022 Direct
Christopher Ellis BRNS Share Option (Right to Buy) Options Exercise -97.6% -39,176 980 25 Aug 2022 Direct
Christopher Ellis BRNS Ordinary Shares Options Exercise 600% 450 525 24 Aug 2022 Direct
Christopher Ellis BRNS Ordinary Shares Sale -85.7% $2,152 $4.78 -450 75 24 Aug 2022 Direct
Christopher Ellis BRNS Share Option (Right to Buy) Options Exercise -1.11% -450 40,156 24 Aug 2022 Direct
Christopher Ellis BRNS Ordinary Shares Options Exercise 2900% 2,175 2,250 18 Aug 2022 Direct
Christopher Ellis BRNS Ordinary Shares Sale -96.7% $10,531 $4.84 -2,175 75 18 Aug 2022 Direct
Christopher Ellis BRNS Share Option (Right to Buy) Options Exercise -5.08% -2,175 40,606 18 Aug 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.